-
3 Reasons Why FDA Rejected MDMA for PTSD Treatment in 2024
Lykos Therapeutics' original application was based on the positive results of two advanced clinical trials that combined MDMA with talk therapy to tre...
2024-08-14 17:35 -
3 Stages of China's Cognitive Impairment Rehabilitation Device Industry's Rapid Growth
As understanding of Alzheimer's disease and mild cognitive impairment deepens, and the concept of early diagnosis and treatment becomes widespread, th...
2024-08-14 17:34 -
The $150B Battle: Lilly's Zepbound and Novo Nordisk's Wegovy Vie for Market Supremacy in the US
As Eli Lilly's (LLY.US) weight-loss drug Zepbound and Novo Nordisk's (NVO.US) Wegovy engage in a fierce competition in the US market, the most pressin...
2024-08-14 17:34 -
SHINEYOMEDICAL Completes Nearly 100 Million Yuan Series A+ Financing, Accelerating the Commercializ...
As a start-up founded only four years ago, SHINEYOMEDICAL has made remarkable achievements in the field of cardiac electrophysiology and peripheral va...
2024-08-13 16:36 -
NMN Found to Effectively Inhibit Cardiomyopathy and Protect Cardiac Health
In recent years, the study of NMN (nicotinamide mononucleotide) has attracted wide attention, and its potential role in regulating heart health has be...
2024-08-13 16:30 -
Capsule Succeeds in Consistency Evaluation, Salbutamol Hydrochloride Capsule Sets New Benchmark
With the continuous advancement of consistency evaluation, in July, Epistine hydrochloride capsule, an important variety, successfully passed the eval...
2024-08-13 16:29 -
Jemperli Approved in Singapore for First-Line Treatment of Advanced or Recurrent Endometrial Cancer ...
On August 7, 2023, GlaxoSmithKline (GSK.US) Singapore announced that the Health Sciences Authority of Singapore (HSA) has approved a new indication fo...
2024-08-13 16:17 -
The World's First Cervical Cancer ADC Drug, Tivdak, Approved In Macau, Bringing New Hope to Chinese ...
TIVDAK is the first cervical cancer ADC drug approved by the U.S. Food and Drug Administration (FDA).
2024-08-13 16:14 -
The Race for China's Next Top Diabetes Drug: Winsunny Pharmaceutical and Yiheng Pharma Vie for Piog...
The news quickly garnered widespread attention as it heralded the arrival of a new player in a high-profile drug market competition.
2024-08-12 17:25 -
Harbour Biomed Regains Global Rights to HBM7008
On August 9, 2024, the company announced that it had successfully won back global development and commercialization rights to HBM7008 from Cullinan On...
2024-08-09 16:47
Hot News
- 关于进一步规范化学品信息发布、... Jan 27, 2026
- BASF’s 2025 Report Card—“Th... Jan 27, 2026
- Invista Reshuffles Global Nylo... Jan 28, 2026
- 5%–10% Is Just the Surface: B... Jan 15, 2026
- “Europe’s Chemical Industry ... Feb 02, 2026
Related Products
Related Producers
